Xsensio has developed the Lab-on-Skin™ sensing platform, a modular and miniaturized device that continuously analyzes proteins and hormones at the skin's surface for real-time health monitoring. This technology addresses the lack of immediate and continuous tracking of critical health parameters, providing unique insights during health events in a minimally invasive manner.
Funding
$13.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
PGWHFounders
Product
Problem
Current methods for monitoring critical health parameters often lack real-time and continuous data collection, hindering early detection of health deterioration. Existing solutions are often invasive or require specialized equipment, limiting their applicability in various settings, including ICUs, outpatient care, and at-home monitoring.
Solution
Xsensio's Lab-on-Skin™ platform is a miniaturized, wearable sensor designed for continuous, real-time biochemical analysis directly on the skin. This modular system monitors proteins and hormones, providing early warnings of physiological changes. By leveraging semiconductor properties, the Lab-on-Skin™ technology enables non-invasive, continuous tracking of key biomarkers, facilitating timely intervention and improved patient outcomes. The initial focus is on early detection of organ dysfunction, addressing critical needs in critical care, oncology, and post-surgical recovery. The platform aims to empower healthcare providers with actionable data for proactive decision-making.
Target Audience
The primary target audience includes healthcare providers in critical care, oncology, and post-surgical settings, as well as patients requiring continuous health monitoring in outpatient or at-home environments.
Features
- Miniaturized sensing platform for continuous monitoring of proteins and hormones on the skin.
- Semiconductor-based technology enabling real-time biochemical analysis.
- Non-invasive monitoring for improved patient comfort and compliance.
- Modular design allowing for a wide range of applications and biomarker detection.
- Focus on early detection of organ dysfunction in critical care, oncology, and post-surgical recovery.